Pediatric Nephrology最新文献

筛选
英文 中文
Long-term kidney side effects of allogeneic hematopoietic stem cell transplantation in children. 儿童异基因造血干细胞移植对肾脏的长期副作用。
IF 2.6 3区 医学
Pediatric Nephrology Pub Date : 2025-12-01 Epub Date: 2025-08-08 DOI: 10.1007/s00467-025-06921-z
Dilek Kaçar, Sare Gülfem Özlü, Özlem Arman Bilir, İkbal Ok Bozkaya, Şerife Mehtap Kanbur, Ayça Koca Yozgat, Özlem Yüksel Aksoy, Umut Selda Bayrakçı, Namık Yaşar Özbek
{"title":"Long-term kidney side effects of allogeneic hematopoietic stem cell transplantation in children.","authors":"Dilek Kaçar, Sare Gülfem Özlü, Özlem Arman Bilir, İkbal Ok Bozkaya, Şerife Mehtap Kanbur, Ayça Koca Yozgat, Özlem Yüksel Aksoy, Umut Selda Bayrakçı, Namık Yaşar Özbek","doi":"10.1007/s00467-025-06921-z","DOIUrl":"10.1007/s00467-025-06921-z","url":null,"abstract":"<p><strong>Background: </strong>Hematopoietic stem cell transplantation (HSCT) is an effective treatment for various childhood diseases with long-term complications, including kidney side effects.</p><p><strong>Methods: </strong>We conducted a single-center retrospective study of 213 patients who received allogeneic HSCT between February 2011 and December 2023. Patients were followed for at least 3 months post-HSCT, with a median follow-up of 2.9 years. We evaluated pre- and post-HSCT estimated glomerular filtration rate (eGFR) and kidney complications.</p><p><strong>Results: </strong>After HSCT, patients showed significantly higher rates of acute kidney injury (21.6% vs. 4.1% pre-HSCT), hypertension (26.8% vs. 5.2% pre-HSCT), and tubulopathy (20.2% vs. 5.2% pre-HSCT). The median final eGFR was 144 mL/min/1.73 m<sup>2</sup>, which was significantly lower than the pre-HSCT eGFR (155 mL/min/1.73 m<sup>2</sup>, p < 0.0001) and negatively correlated with time after HSCT (Rs =  - 0.177, p = 0.009). Eight patients (3.8%) progressed to chronic kidney disease (CKD). Factors linked to CKD included inherited bone marrow failure syndromes, anti-thymocyte globulin (ATG) conditioning, urinary tract infections (UTIs), and high urinary BK virus loads. Although the rates of glomerular hyperfiltration (GHF) did not change significantly between pre-HSCT (63.8%) and post-HSCT (62.4%, p = 0.824), GHF was notable in patients with acute lymphoblastic leukemia pre-HSCT and thalassemia post-HSCT. Seventeen patients (8.4%) needed ongoing antihypertensive treatment.</p><p><strong>Conclusions: </strong>HSCT can cause various kidney complications. GHF is common both before and after transplant, and eGFR often declines over time. UTIs, ATG conditioning, and inherited bone marrow failure syndromes are important risk factors for CKD. Individual factors and infection surveillance should be considered in these patients to approach kidney health.</p>","PeriodicalId":19735,"journal":{"name":"Pediatric Nephrology","volume":" ","pages":"3775-3783"},"PeriodicalIF":2.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144799795","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anti-CD20 monoclonal antibodies for idiopathic nephrotic syndrome: Advances, challenges, and future directions. 抗cd20单克隆抗体治疗特发性肾病综合征:进展、挑战和未来方向
IF 2.6 3区 医学
Pediatric Nephrology Pub Date : 2025-12-01 Epub Date: 2025-05-01 DOI: 10.1007/s00467-025-06738-w
Andrea Angeletti, Gian Marco Ghiggeri
{"title":"Anti-CD20 monoclonal antibodies for idiopathic nephrotic syndrome: Advances, challenges, and future directions.","authors":"Andrea Angeletti, Gian Marco Ghiggeri","doi":"10.1007/s00467-025-06738-w","DOIUrl":"10.1007/s00467-025-06738-w","url":null,"abstract":"","PeriodicalId":19735,"journal":{"name":"Pediatric Nephrology","volume":" ","pages":"3597-3600"},"PeriodicalIF":2.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143992159","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Critical insights on post-infectious glomerulonephritis among children before and during the COVID-19 pandemic. COVID-19大流行之前和期间儿童感染后肾小球肾炎的重要见解
IF 2.6 3区 医学
Pediatric Nephrology Pub Date : 2025-11-01 Epub Date: 2025-06-30 DOI: 10.1007/s00467-025-06886-z
Sadeeq Khan, Abdur Rehman, Waheed Khan
{"title":"Critical insights on post-infectious glomerulonephritis among children before and during the COVID-19 pandemic.","authors":"Sadeeq Khan, Abdur Rehman, Waheed Khan","doi":"10.1007/s00467-025-06886-z","DOIUrl":"10.1007/s00467-025-06886-z","url":null,"abstract":"","PeriodicalId":19735,"journal":{"name":"Pediatric Nephrology","volume":" ","pages":"3591"},"PeriodicalIF":2.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144529202","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evidence-based risk stratification for neonatal acute kidney injury: a call to action. 新生儿急性肾损伤的循证风险分层:行动呼吁。
IF 2.6 3区 医学
Pediatric Nephrology Pub Date : 2025-11-01 Epub Date: 2025-03-27 DOI: 10.1007/s00467-025-06752-y
Tahagod Mohamed, Nicole Asdell, Xia Ning, Jason G Newland, Matthew W Harer, Cara L Slagle, Michelle C Starr, John D Spencer, Francis P Wilson, David T Selewski, Jonathan L Slaughter
{"title":"Evidence-based risk stratification for neonatal acute kidney injury: a call to action.","authors":"Tahagod Mohamed, Nicole Asdell, Xia Ning, Jason G Newland, Matthew W Harer, Cara L Slagle, Michelle C Starr, John D Spencer, Francis P Wilson, David T Selewski, Jonathan L Slaughter","doi":"10.1007/s00467-025-06752-y","DOIUrl":"10.1007/s00467-025-06752-y","url":null,"abstract":"","PeriodicalId":19735,"journal":{"name":"Pediatric Nephrology","volume":" ","pages":"3335-3339"},"PeriodicalIF":2.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143720452","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of losartan on uric acid metabolism in children with proteinuric kidney disease: crossover randomized controlled clinical trial. 氯沙坦对蛋白尿肾病患儿尿酸代谢的影响:交叉随机对照临床试验
IF 2.6 3区 医学
Pediatric Nephrology Pub Date : 2025-11-01 Epub Date: 2025-06-26 DOI: 10.1007/s00467-025-06754-w
Laura Beaudoin, Luciana Meni Battaglia, Sandra Mariel Martin, Ismael Toledo, Alejandro Balestracci
{"title":"Effect of losartan on uric acid metabolism in children with proteinuric kidney disease: crossover randomized controlled clinical trial.","authors":"Laura Beaudoin, Luciana Meni Battaglia, Sandra Mariel Martin, Ismael Toledo, Alejandro Balestracci","doi":"10.1007/s00467-025-06754-w","DOIUrl":"10.1007/s00467-025-06754-w","url":null,"abstract":"<p><strong>Background: </strong>Low uric acid (UA) levels are desirable in kidney disease. Enalapril is the most used reno-protective drug; losartan has a similar antihypertensive and antiproteinuric effect, but also induces hyperuricosuria due to tubular urate transporter 1 inhibition. As this effect has not been demonstrated in paediatrics, we assessed if losartan reduces serum UA in children, owing to an increase in its urinary excretion, compared to enalapril.</p><p><strong>Methods: </strong>Single-centre, open-label, crossover randomized trial. Patients aged 3-12 years with proteinuric kidney disease and estimated glomerular filtration rate ≥ 30 ml/min/1.73 m<sup>2</sup>, were assigned to receive enalapril or losartan for 30 days. Then, all patients received 15-days of enalapril to washout the effect of losartan in those who received it. Subsequently, they were switched to the opposite treatment modality.</p><p><strong>Results: </strong>Forty patients were included (36 CKD stage 1, 4 stage 2), median age 8.58 years; median serum UA 4 mg/dL (IQR, 3.5-5.1). Losartan significantly increased median UA urinary fractional excretion from 7% (IQR 6-8.27) to 8.9% (IQR 6.3-11) (p < 0.001) and significantly reduced its median serum level from 4.2 mg/dL (IQR 3.4-4.9) to 3.6 mg/dL (IQR 2.9-4.5) (p < 0.001). Median urinary excretion [pre 6.65% (IQR 5-8.41) vs. post 7% (IQR 5.5-8.3), p = 0.61)] and median serum values [pre 4.2 mg/dL (IQR 3.6-5.1) vs. post 4.1 mg/dL (IQR 3.4-5), p = 0.42)] were comparable with enalapril. The decrease in serum UA levels post-losartan correlated with the increase in its urinary excretion (r = -0.33; p = 0.036).</p><p><strong>Conclusions: </strong>Losartan significantly increased UA urinary excretion along with the consequent reduction in its serum levels.</p>","PeriodicalId":19735,"journal":{"name":"Pediatric Nephrology","volume":" ","pages":"3495-3503"},"PeriodicalIF":2.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144507323","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In vitro measurements of ultrafiltration precision in hemofiltration and hemodialysis devices used in infants, Part 2: Comparison of PrisMax and CARPEDIEM with previous data on NIDUS, Prismaflex and Aquarius. 婴儿血液滤过和血液透析装置超滤精度的体外测量,第2部分:PrisMax和CARPEDIEM与NIDUS、Prismaflex和Aquarius先前数据的比较
IF 2.6 3区 医学
Pediatric Nephrology Pub Date : 2025-11-01 Epub Date: 2025-07-08 DOI: 10.1007/s00467-025-06788-0
Jean Crosier, Denise Colosimo, Rachel Hansen, Heather J Lambert, Malcolm G Coulthard, Zaccaria Ricci
{"title":"In vitro measurements of ultrafiltration precision in hemofiltration and hemodialysis devices used in infants, Part 2: Comparison of PrisMax and CARPEDIEM with previous data on NIDUS, Prismaflex and Aquarius.","authors":"Jean Crosier, Denise Colosimo, Rachel Hansen, Heather J Lambert, Malcolm G Coulthard, Zaccaria Ricci","doi":"10.1007/s00467-025-06788-0","DOIUrl":"10.1007/s00467-025-06788-0","url":null,"abstract":"<p><strong>Background: </strong>We sought to determine in vitro whether the PrisMax and CARPEDIEM hemofiltration and hemodialysis devices can reliably deliver ultrafiltration (UF) control that is sufficiently precise to treat infants.</p><p><strong>Methods: </strong>We have previously measured the precision of UF control of the Prismaflex, Aquarius and NIDUS devices by in vitro testing with a bag of saline set up as a dummy patient, and comparing the differences between the UF set and displayed by the devices, and the actual fluid removal or addition measured by precise weighing. Here we have tested the PrisMax (updated version of Prismaflex) and the CARPEDIEM using the same method.</p><p><strong>Results: </strong>The variances of the setting vs. actual errors, and display vs. actual errors after 15 min of 'treatment' with the PrisMax and CARPEDIEM were similar, but were significantly larger than in the NIDUS, and much smaller than in the Prismaflex. However, after a 4-h 'treatment session', the cumulative errors were still within ± 9 mL for these devices, compared with a maximum error of 2.6 mL in the NIDUS, and a deviation of -37.5 mL in the Prismaflex.</p><p><strong>Conclusions: </strong>The PrisMax and the CARPEDIEM have adequate precision to be used in infants. The only device with UF error below 3 ml in 4 h is the volumetrically-controlled NIDUS. We recommend that regulatory bodies should introduce UF precision-testing for devices intended for use in infants.</p>","PeriodicalId":19735,"journal":{"name":"Pediatric Nephrology","volume":" ","pages":"3549-3554"},"PeriodicalIF":2.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12484341/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144584490","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Urinary DKK3 in Alport syndrome: early marker or epiphenomenon? Alport综合征尿DKK3:早期标志还是附带现象?
IF 2.6 3区 医学
Pediatric Nephrology Pub Date : 2025-11-01 Epub Date: 2025-06-27 DOI: 10.1007/s00467-025-06879-y
Iqra Nasir, Fida Hussain, Muhammad Ibrahim
{"title":"Urinary DKK3 in Alport syndrome: early marker or epiphenomenon?","authors":"Iqra Nasir, Fida Hussain, Muhammad Ibrahim","doi":"10.1007/s00467-025-06879-y","DOIUrl":"10.1007/s00467-025-06879-y","url":null,"abstract":"","PeriodicalId":19735,"journal":{"name":"Pediatric Nephrology","volume":" ","pages":"3589"},"PeriodicalIF":2.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144507324","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IPNA webinars: an effective teaching platform advancing patient care in pediatric nephrology worldwide. IPNA网络研讨会:一个有效的教学平台,在全球范围内推进儿科肾脏病患者护理。
IF 2.6 3区 医学
Pediatric Nephrology Pub Date : 2025-11-01 Epub Date: 2025-04-17 DOI: 10.1007/s00467-025-06775-5
Eugene Yu-Hin Chan, Sharon Teo, Michelle López, Abdullahi Mudi, Pankaj Hari, Olivia Boyer, John D Mahan, Dieter Haffner, Elena Levtchenko
{"title":"IPNA webinars: an effective teaching platform advancing patient care in pediatric nephrology worldwide.","authors":"Eugene Yu-Hin Chan, Sharon Teo, Michelle López, Abdullahi Mudi, Pankaj Hari, Olivia Boyer, John D Mahan, Dieter Haffner, Elena Levtchenko","doi":"10.1007/s00467-025-06775-5","DOIUrl":"10.1007/s00467-025-06775-5","url":null,"abstract":"","PeriodicalId":19735,"journal":{"name":"Pediatric Nephrology","volume":" ","pages":"3341-3345"},"PeriodicalIF":2.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144047432","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Toward better outcomes in pediatric septic shock: the role of practical risk models. 迈向儿童感染性休克的更好结局:实用风险模型的作用。
IF 2.6 3区 医学
Pediatric Nephrology Pub Date : 2025-11-01 Epub Date: 2025-08-15 DOI: 10.1007/s00467-025-06907-x
Ziwei Zhao, Hujie Dong, Huihua Zhu
{"title":"Toward better outcomes in pediatric septic shock: the role of practical risk models.","authors":"Ziwei Zhao, Hujie Dong, Huihua Zhu","doi":"10.1007/s00467-025-06907-x","DOIUrl":"10.1007/s00467-025-06907-x","url":null,"abstract":"","PeriodicalId":19735,"journal":{"name":"Pediatric Nephrology","volume":" ","pages":"3593-3594"},"PeriodicalIF":2.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144855952","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidemiology and outcome of pediatric acute kidney injury-multicenter observational study from a low-middle-income country. 儿童急性肾损伤的流行病学和结局——来自中低收入国家的多中心观察性研究。
IF 2.6 3区 医学
Pediatric Nephrology Pub Date : 2025-11-01 Epub Date: 2025-07-01 DOI: 10.1007/s00467-025-06856-5
Uma Ali, Amol Madave, Kinnari Vala, Sadhana Zope, Manoj Matnani, Jyoti Singhal, Anupama Mauskar, Poonam Wade, Radha Ghildiyal, Jyoti Sharma, Madhulika Chakravarthi, Puneet Chhajed, Nivedita Pande, Nisha Krishnamurthy, Aarthi Prasanna, Kiran Sathe, Atul Deokar, Manish Arya, Vaibhav Keskar, Pawan Deore
{"title":"Epidemiology and outcome of pediatric acute kidney injury-multicenter observational study from a low-middle-income country.","authors":"Uma Ali, Amol Madave, Kinnari Vala, Sadhana Zope, Manoj Matnani, Jyoti Singhal, Anupama Mauskar, Poonam Wade, Radha Ghildiyal, Jyoti Sharma, Madhulika Chakravarthi, Puneet Chhajed, Nivedita Pande, Nisha Krishnamurthy, Aarthi Prasanna, Kiran Sathe, Atul Deokar, Manish Arya, Vaibhav Keskar, Pawan Deore","doi":"10.1007/s00467-025-06856-5","DOIUrl":"10.1007/s00467-025-06856-5","url":null,"abstract":"<p><strong>Background: </strong>The epidemiology and outcome of acute kidney injury (AKI) in low-middle-income countries (LMICs) differ from those in high-income countries due to differences in type and severity of non-renal systemic illness and variability in nephrology-care facilities. There is a paucity of multicenter studies from LMICs. This multicenter observational study was undertaken to study the epidemiology of pediatric AKI in a LMIC and analyze the significance of associated sample characteristics and interventions on outcomes, namely renal recovery and mortality.</p><p><strong>Methods: </strong>Children (1 month-18 years) diagnosed with AKI, based on KDIGO criteria, seen in 10 centers, over 30 months, were included. Data collected included hospital type, city, patient demographics, illness characteristics, pre-existing diseases, AKI profile, interventions including mechanical ventilation (MV), vasoactive drugs (VADs), nephrotoxic drugs, radiocontrast exposure, and recent surgery. Use of kidney replacement therapy (KRT), modality, renal recovery, and patient survival was assessed.</p><p><strong>Results: </strong>Non-renal systemic illness accounted for 79% of cases. Majority were infections. Pre-existing illness was present in 55%, with 29% having kidney disease. AKI was diagnosed at admission in 68%, with 40% in KDIGO stage 3; 50% had severe AKI. MV and VADs were used in 42% and 46%, respectively. KRT was required in 29%, most receiving acute peritoneal dialysis (58%). Complete recovery (CR) was seen in 44%, while 29.6% died. Pre-existing kidney disease and KRT negatively impacted CR. VAD use was linked to mortality, and CR was associated with survival.</p><p><strong>Conclusions: </strong>Non-renal systemic infection was the leading cause of AKI characterized by early, rapid progression, severe in 50%, high need for KRT, CR in less than 50% and high mortality.</p>","PeriodicalId":19735,"journal":{"name":"Pediatric Nephrology","volume":" ","pages":"3539-3547"},"PeriodicalIF":2.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144541800","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信